The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
Recruiting
Observational Study
Takotsubo Cardiomyopathy
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Cedars-Sinai Medical Center · Other
Who this trial is looking for
This trial is looking for people who have been diagnosed with Takotsubo cardiomyopathy and agree to participate. Participants will share their medical records and provide a blood sample from home for research purposes.
Are You a Good Fit for This Trial?
You may be able to join if
I have been diagnosed with Takotsubo
I consent to enroll
I can submit full medical records
You may not be able to join if
I am younger than 18 years
I am unable to provide informed consent
I cannot provide the necessary documentation
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusion/exclusion criteria of Takotsubo Registry protocol. Subjects will also be invited to provide a blood sample utilizing a…
The Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusion/exclusion criteria of Takotsubo Registry protocol. Subjects will also be invited to provide a blood sample utilizing a Mitra kit sent to their homes. Researchers from the Barbra Streisand Women's Heart Center will analyze Registry data to identify Takotsubo phenotypes, improve diagnostic capabilities, better predict recurrence rates, and develop targeted Takotsubo treatments.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Have received a diagnosis of Takotsubo from their physician and consent to enroll
* Submit full medical records needed for Takotsubo adjudication
Exclusion Criteria:
* Younger than 18 years
* Unable to provide informed consent
* Unable to provide the necessary documentation …
Inclusion Criteria:
* Have received a diagnosis of Takotsubo from their physician and consent to enroll
* Submit full medical records needed for Takotsubo adjudication
Exclusion Criteria:
* Younger than 18 years
* Unable to provide informed consent
* Unable to provide the necessary documentation needed for screening purposes
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.